METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in adults for: - Prevention of postoperative nausea and vomiting (PONV) - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - Prevention of nausea and vomiting caused by radiation therapy - Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - Diabetic gastroparesis - To faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) Pediatric population. METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in children aged 1 to 18 years for: - Second line-therapy: Treatment of established postoperative nausea and vomiting (PONV) - Second-line therapy: Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - To facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations).